Oertel, Michael
Borrmann, Katrin
Baehr, Andrea
Eich, Hans Theodor
Greve, Burkhard
Funding for this research was provided by:
Innovative Medical Research of the University of Münster Medical School (OE 212103, OE 212103, OE 212103, OE 212103, OE 212103)
Universitätsklinikum Münster
Article History
Received: 19 July 2022
Accepted: 21 November 2022
First Online: 28 November 2022
Declarations
:
: The study was designed as a prospective biomarker protocol and approved by our institutional review board (2016-664-f-S with an amendment on 02nd March 2021 for the analysis of PD-L2, CTLA-4 and IL-6) and executed according to the principles of the declaration of Helsinki. Written informed consent was given by all patients and volunteers involved.
: All authors agreed on the final form of the manuscript.
: Not applicable.